Imbria Presents Positive Clinical Data from Phase 2 IMPROVE-DiCE Trial of Ninerafaxstat in Patients with Cardiometabolic HFpEF at ACC.25
Ninerafaxstat improves cardiac energetics, cardiac reserve capacity, 6-minute walk distance and heartfailure-related health status (KCCQ) in ...
HYTN Secures Strategic Supply Agreements and Qualifies 4000kg of Cannabis for German Market
HYTN anticipates the arrival of the initial cultivation batches for GMP processing in Q2 2025, with the first shipments to Germany expected in late Q2 2025. 1. Johnny Green, "Legal Medical Cannabis ...
BioPharma Dive20h
FDA approves first-of-its-kind RNA drug for hemophilia
The Sanofi drug, known as fitusiran and now Qfitlia, was approved on Friday for a broad group of people with the rare ...
US FDA approves Sanofi's bleeding disorder therapy
The U.S. Food and Drug Administration approved French drugmaker Sanofi's hemophilia therapy, introducing a new type of ...
BizWest22h
Bayswater completes $603M sale of D-J Basin assets
Bayswater Exploration and Production LLC, a Denver-based oil and natural-gas development company, has closed the sale of ...